Season 4 I Episode 16 I The Hidden Battle: How MRD Testing is Changing Cancer Care Artwork

Deep Tech Talk

Welcome to Deep Tech Talk Podcast by BIS Research. The impact of Deep Tech is expected to shake up the industry. Through this podcast, we would be sharing new innovations, upcoming trends, industry advancements, along with factors that are going to be the turning point in the dynamics of the market. So it's important to listen to all our episodes to keep yourself updated with all the major happenings. Established in 2014, BIS Research is well known for tracking the growth of deep technologies across key industry verticals such as healthcare, space, aerospace, automotive, mobility, robotics, materials, defense, food tech, agritech, communication technologies, and more. With more than 1,000 clients, over 10,000 plus primary interviews, and approximately 200 market intelligence reports published in a year, BIS Research has often been sighted for its ability to track deep tech trends early on. We provide market estimations, analysis on emerging high-growth applications, technology analysis, highly segmented granular country-level market data, and other important market parameters that come in handy for our clients during strategic decision-making. To know more about the impact of deep tech in your industry, please visit our website at www.bisresearch.com.

All Episodes

Deep Tech Talk

Season 4 I Episode 16 I The Hidden Battle: How MRD Testing is Changing Cancer Care

March 21, 2025 • BIS Research • Season 4 • Episode 16

In this episode of Deep Tech Talk, Chris delves into the technical advancements of MRD (Minimal Residual Disease) testing in oncology. Explore the precision of next-gen sequencing and digital PCR in detecting microscopic traces of cancer post-treatment. Learn about industry leaders like F. Hoffmann-La Roche, Guardant Health, and Adaptive Biotechnologies, and the role of MRD testing in personalized medicine and early relapse detection. Tune in for an in-depth look at the future of precision cancer diagnostics.

#MRDTesting #MinimalResidualDisease #CancerCare #PrecisionOncology #NextGenSequencing #DigitalPCR #CancerDetection #OncologyInnovation #PersonalizedMedicine #LiquidBiopsy #AdaptiveBiotechnologies #GuardantHealth #FhoffmannLaRoche #EarlyDetection #CancerResearch #OncologyTech #DeepTech #TechInMedicine #HealthTech #FutureOfCancerCare